IMPROVEMENTS IN SENSITIVITY FOR BIOANALYSIS OF WARFARIN USING ACQUITY™ PREMIER UPLC SYSTEM AND XEVO™ TQ ABSOLUTE TANDEM QUADRUPOLE MASS SPECTROMETER

Posters | 2022 | Waters | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Quantification of Warfarin and Furosemide in Human and Rat Plasma for Discovery Bioanalysis Using ACQUITY™ Premier UPLC™ System and Xevo™ TQ Absolute Mass Spectrometer
Versatile LC-MS/MS Solutions for the Evolving Bioanalysis Landscape
Comprehensive Workflow for the Quantification of Peptides and Proteins in Plasma: Semaglutide– a Case Study
A Streamlined Workflow for Quantitative Bioanalysis using waters_connect for Quantitation Software: A Case Study Using Gefitinib